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Abstract
Introduction and objective. Aging is a process that also affects the autonomic nervous system (ANS) making it less adaptable 
to environmental and intrinsic stimuli and affecting its ability to maintain body homeostasis. The aim of this study was to 
estimate the resting ANS function using heart rate variability (HRV) method and by noradrenaline measurement in aging, 
2–12-months-old rats.  
Materials and method. Resting 15-minute-long ECG recordings were performed in anaesthetized rats with a subsequent 
spectral HRV analysis. Basic non-normalized HRV components in the range of very low (VLF), low (LF) and high (HF) frequency, 
along with the total HRV spectrum power (TP) were estimated. Moreover, normalized LF (nLF) and normalized HF (nHF) 
were calculated. Blood samples were also collected to assay plasma noradrenaline (NA) level.  
Results. In the overall assessment, plasma noradrenaline level as well as both TP and all non-normalized HRV components 
demonstrated a tendency for reduction when compared the first (2nd) and last (12th) months. In the case of nLF and nHF, 
a trend of nLF predominance in the 2nd and 3rd month was revealed while an inverse relation was observed from the 6th 
month on, with nHF superiority. Overall, males reached comparable or slightly higher NA and non-normalized HRV values 
compared to females, although most differences were not statistically significant. A parallel decline of LF (starting from the 
10th month) and HF (from the 6th month) was demonstrated in both male and female animals. Female rats had a little more 
stable nLF and nHF course in the study time.  
Conclusions. Rat ANS aging is associated with global HRV decrease with parallel plasma NA decline, although without 
selective impairment of individual (sympathetic/parasympathetic) ANS components.
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INTRODUCTION
The autonomic nervous system (ANS) is essential for fast and 
adequate adaptation of visceral function in response to the 
continuously changing external and internal environment 
(maintenance of homeostasis).
Functionally, ANS is immature at birth and undergoes 
postnatal maturation. There is a general belief that the 
parasympathetic ANS branch is more developed compared to 
the sympathetic one at birth. The latter is thought to reach its 
full activity after several months of postnatal life, depending 
on the species (including humans) [1]. That statement is 
based on both histochemical and physiological data. The 
histochemical marker for sympathetic innervation – tyrosine 
hydroxylase – increases progressively in canine heart until 
2 months after birth [2]. Human immunohistochemical 
studies also revealed that the density of cardiac sympathetic 
innervation (indicated by tyrosine hydroxylase and dopamine 
beta-hydroxylase) is significantly less in the newborn heart 
than in the adult one [3].
The whole period after completion of the maturation 
process may be trivially referred to as a progressive ageing 
process. Thus, ageing is a gradual, continuous process of 
changes continuing throughout the mature life. Ageing or 
senescence can be considered as a sum of losses of both 
functions and morphological structures. That process also 
affects the ANS [4]. The indirect evidence supporting the 
thesis of overall decline in the ANS function with age is 
the progressive, age-dependent function deterioration of 
systems under autonomic control. Therefore, the incidence 
of numerous diseases increases with age and, on the 
other hand, the course of many chronic diseases becomes 
deteriorated by autonomic nervous system dysfunction 
[5]. Alterations affecting both the central and peripheral 
neuronal structures, being parts of both the somatic and the 
autonomic nervous system, include loss of the total neuronal 
count and reconstruction of remaining neurons (decrease 
of axons, disturbed myelination). The decrease of melanin 
and dopamine (especially in substantia nigra) along with the 
decline in many other neurotransmitter levels have been also 
reported. Another important issue is the loss of numerous 
neuronal receptors and their diminished affinity to their 
specific agonists [5, 6].
There are many studies evaluating the impaired autonomic 
nervous system function in various conditions, primarily 
based on various clinical, dynamic methods of the ANS 
assessment (e.g. using so-called autonomic tests – intentional 
induction and assessment of certain cardiovascular reflexes). 
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Although aging (including ANS senescence) is an obvious 
physiological process, it remains poorly understood. Clinical 
reports providing a detailed characterization of age-related 
functional ANS changes are scant. Moreover, there are no 
experimental research programmes devoted to evaluation 
of resting activity of the aging ANS.
This is partly due to technical difficulties – in practice, 
there is no direct assessment of the autonomic nervous 
system activity using some reliable laboratory techniques 
or direct neurophysiological records; and available, indirect 
methods are based on the assessment of autonomically-
controlled effects. There are some possibilities of functional 
ANS assessment presented in numerous reviews [7–10], 
including our previously published paper [11]. One of the 
most widely used and readily available method of both 
clinical and experimental ANS activity assessment is the 
heart rate variability (HRV) [12]. This refers to the beat-
to-beat (N-N; ‘normal-normal’) variation in the heart rate 
recorded in the ECG, resulting from the interplay of the 
sympathetic and parasympathetic modulation of the sinus 
node of the heart.
In addition, plasma noradrenaline measurement is regarded 
to be a laboratory surrogate marker of the sympathetic 
activity [11].
OBJECTIVES
The study aimed to estimate changes in the resting spectral 
heart rate variability, and the plasma noradrenaline level 
in anaesthetized rats throughout 2–12 months of life. The 
zootechnical data indicate that rat reaches sexual maturity 
5–8 weeks after birth, and full housing maturity in about 8–10 
weeks, while the rat’s average life expectancy is about 2 years 
[13,14]. Considering these data, it could be stated that animals 
ending the puberty period (2 months-old) and completely 
mature (3–12 months-old), already aging, were studied.
MATERIAL AND METHODS
The study was approved by the First Local Ethical Committee 
for Animal Experiments in Krakow.
General plan of the experiment. The study was carried 
out on laboratory Wistar rats, 2–12 months-old, obtained 
from the central animal house of the Faculty of Pharmacy 
UJCM in Krakow. Before reaching the desired age, animals 
were kept in the above-mentioned research unit and were 
subsequently transferred to a local animal house of the 
Department of Pathophysiology UJCM. Upon arrival, 
animals acclimatized to new living conditions for 10 days. 
Rats were housed in unisex groups and depending on their 
age and weight, they were kept in groups of 2–3 individuals 
in standard laboratory cages, with unlimited access to water 
and laboratory chow (Biowet, Pulawy), with the addition of 
‘enrichments’ to ensure complete animal welfare. During that 
period, rats were subject to daily observation and handling, 
allowing confirmation of their good health and physiological 
state.
After the acclimatization period, general anesthesia was 
induced in individual animals to perform the standardized 
ECG records followed by the HRV analysis.
Finally, after administration of a dose of sodium 
pentobarbital(400 mg/kg b.w.), blood samples were collected 
from each animal. Plasma was separated and stored at -70 °C 
for further biochemical assay of noradrenaline concentration.
Studied animals. 2, 3, 4, 6, 8, 10 and 12 months-old rats, both 
males (M) and females (F) rats were enrolled. Depending on 
the gender and age of the animals, 14 groups of 6 animals 
each were examined (mean body weight [g] ± SEM in each 
study group was given in the parentheses below): M2M (male; 
2 months; 281.8±12.6), F2M (female; 2 months; 196.3±15.6), 
M3M (male; 3months; 282.9±12.0), F3M (female; 3 months; 
207.0±26.0), M4M (male; 4 months; 359.4±38.3), F4M (female; 
4 months; 211.3±21.7), M6M (male; 6 months; 450.8±59.6), 
F6M (female; 6 months; 248.8±16.3), M8M (male; 8 months; 
460.3±52.0), F8M (female; 8 months; 243.2±10.4), M10M 
(male, 10 months; 479.2±38.6), F10M (female; 10 months; 
287.3±11.4), and M12M (male, 12 months; 516.0±26.9), F12M 
(female; 12 months; 276.5±21.1). The total number of animals 
used in the experiment was 84.
ECG recordings and HRV analysis methods. The ECG 
was recorded under general pentobarbital sodium-induced 
anaesthesia (Morbital, 50 mg per kg body weight, i.p.) and 
20-min rest. Before the recordings, the abdominal fur was 
removed, rats’ abdomens were carefully shaved in order 
to achieve epidermal abrasion and a standard ECG gel 
was applied. Recordings were collected with paediatric 
Ag/AgCl probes (EG-S30 PSG Sorimex), deployed in the 
classic configuration in order to obtain one ECG lead, and 
the ADInstruments hardware (Power Lab 4/30 and BIO 
Amplifier). The fragment, including the first 5 minutes, was 
excluded from subsequent analysis and was regarded as the 
time necessary for signal calibration and adaptation of the 
study individual to new experimental conditions. During 
the registration, rats were placed under a heating lamp to 
protect them from body temperature drop.
Once registrations were completed, the 15-minute-long 
ECG signal was visually evaluated to remove ectopic beats, 
and the remaining records were subject to the HRV analysis, 
using the ADInstruments software (Chart v5.4.2) for Mac 
OS X Version 10.1.2. According to the HRV guidelines, both 
time- and spectral domain analysis are recommended for 
long-lasting (especially 24-hour) ECG recordings, while short 
ones (5–30 minutes) should be subjected only to the spectral 
(frequency) analysis [12].
HRV analysis is based on the variability of duration 
of adjacent, ‘normal-normal’ (N-N) intervals, subject to 
continuous, ANS-modulated fluctuations. The spectral 
(frequency) HRV analysis results from subjecting of the 
N-N intervals variability to fast-Fourier transformation 
or autoregression methods. In that procedure, the total 
power(TP) of HRV spectrum is determined along with the 
powers (in [ms2]) of its basic components, resulting from 
distribution of RR intervals variability in relation to cyclic, 
ANS-modulated stimulating activity of the sinus node 
associated with 3 principal rhythms: very low frequency 
(VLF), low frequency (LF), and high frequency (HF) [12].
In clinical studies, ranges for the individual spectral 
components are: 0.003<VLF<0.04<LF<0.15<HF<0.4. 
Taking into account a rat’s heart rate (much higher 
than in humans), the following ranges were adopted for 
individual HRV spectral components for the spectral HRV 
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analysis: 0.18<VLF<0.28<LF<0.78<HF<3. The frequency 
ranges adopted were similar to those used by Aubert et al. 
[15] (0.19<LF<0.74<HF<2.5) and Goncalves et  al. [16] 
(0.10<LF<1.0<HF<3.0).
Total HRV spectrum power is said to reflect the global 
autonomic activity. Spectral HRV components are considered 
to be correlated with physiological functions: LF is regarded 
to be a marker of both sympathetic and vagal tension, also 
reflecting baroreflex sensitivity, while HF is agreed to be a 
selective, vagal –dependent HRV spectrum component. The 
VLF origin, although it constitutes the majority of the HRV 
spectrum, is the most controversial one, probably resulting 
from thermoregulatory and neuroimmunological processes 
and the cyclic activation of various regulatory mechanisms 
(e.g. renin-angiotensin-aldosterone system) [7–10].
Subjecting the HRV spectrum to the process of 
normalization, we also calculated the normalized nHF 
and nLF values, that are regarded to reflect the selective 
parasympathetic and sympathetic tension, respectively. The 
HRV spectrum normalization is based on the calculation of 
the share of respective components (LF or HF) in the total 
HRV power, excluding the VLF component power. That 
procedure results from difficulties in interpretation of the 
VLF component [8–11].
Noradrenaline assessment: Rat noradrenaline was measured 
in plasma samples using a commercially available ELISA kit 
(LDN; Labor Diagnostica Nord, GmbH & Co. KG; Nordhorn, 
Germany), strictly according to the manufacturer’s instructions. 
Noradrenaline concentrations (ng/ml) in appropriate groups 
and time points (along with the total estimation) were assessed.
Statistical analysis. Since the calculated HRV parameters 
were characterized by large intragroup differences, 
manifested by high values of standard deviations, the output 
HRV parameters were subjected to logarithmic forms to 
ensure better approximation to normal distribution. The 
analysis estimating age and gender-dependent difference 
was performed using paired Student’s t-test, separately for 
each paired (male-female) groups for each study month.The 
statistical significance level was set as p ≤ 0.05.
RESULTS
Overall assessment
Noradrenaline. In the 2nd and 3rd month, comparable 
NA concentrations were noted. From the 4th month on, a 
continuous decrease was observed which was particularly 
pronounced in the last (10th and 12th) months of the 
experiment.
HRV. In the case of both TP and VLF, a progressive, 
continuous increase was noted in the 2nd and 3rd months, with 
a plateau in the 4th month,and with a subsequent decrease in 
the following months.
Considering LF and HF changes, it was demonstrated 
that HF reached higher values compared to LF in all study 
months, except for the last, 12th month, when LF achieved 
a slightly larger value. Analyzing the LF and HF changes in 
time, a stable course or progressive decline was noted, except 
for a transient LF and HF increase in the 6th month.
In case of nLF and nHF, a trend of nLF predominance in 
the 2nd and 3rd months was observed, while from the 6th month 
on, an inverse relation was observed, with nHF superiority. 
In the 4th month, there was a perfect balance between nLF 
and nHF.
Detailed results of the logarithmic values of both NA 
concentrations and spectral HRV parameters in studied 
rats, without gender differentiation, are given in (Table 1).
Gender and age dependent HRV and NA differences. 
Detailed results (expressed in logarithmic values of NA 
concentration and HRV parameters), revealed separately in 
male and female animals, along with the statistical reasoning, 
are presented in Table 2.
Noradrenaline. Considering the NA differences, almost 
the same plasma NA levels were observed in the 2nd, 3rd and 
4th months,while from the 6th month on, some significantly 
higher values were observed in males. On the other hand, 
in the 12th month, a slightly higher value was demonstrated 
for female rats.
The trend of the course of the plasma NA changes during the 
study months is presented in the Figure 1 (graph represents 
mean values calculated for studied months). Moreover, the 
curve, created by connecting points determined in studied 
months, also demonstrates some hypothetical values for 
those months in which no HRV assessment was performed.
HRV. Male animals had higher TP values comparing to 
females in the first 6 study months. In the 8th month, the 
relationship became inverse, and starting from and 10th 
month the male predominance was observed again. In 
general, the courses of TP decline, were almost parallel in 
male and female rats, except for the 8th month. VLF changes 
were more irregular, especially those observed during months 
6–12.
Table 1. Logarithmic plasma noradrenaline (NA) concentrations (mean±SD), spectral HRV parameters (mean±SD) and resting heart rate (HR; mean±SD) 
in individual months of the experiment – overall assessment (for both males and females)
NA
[ln ng/ml]
TP
[ln ms2]
VLF
[ln ms2]
LF
[ln ms2]
HF
[ln ms2]
nLF
[ln n.u.]
nHF
[ln n.u.]
HR
[1/min]
2M 2.82±0.11 3.79±0.66 3.15±0.57 2.00±0.94 2.37±0.99 4.04±0.17 3.71±0.28 374.54±26.75
3M 2.86±0.17 4.12±0.69 3.62±0.89 2.08±0.69 2.14±1.09 3.90±0.57 3.77±0.29 349.33±18.72
4M 2.37±0.57 4.14±0.35 3.64±0.57 2.09±0.65 2.11±0.89 3.88±0.32 3.88±0.22 368.35±26.09
6M 2.28±0.47 3.83±1.34 3.41±1.28 2.42±0.37 2.52±0.87 3.79±0.48 3.89±0.33 350.65±14.79
8M 2.01±0.52 3.06±1.15 2.68±1.00 0.81±1.29 1.31±1.71 3.54±0.64 4.04±0.35 357.29±19.94
10M 0.82±0.78 3.34 ±0.68 2.80±0.79 1.21±1.19 1.40±1.32 3.79±0.26 3.98±0.21 357.63±19.48
12M -0.59±0.55 2.53±0.99 2.32±1.16 -0.31±0.97 -0.21±0.63 3.76±0.64 3.88±0.34 344.29±16.97
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In the LF analysis, higher values for male rats were 
demonstrated in months 2–6 (however, the difference was 
statistically significant only in the 4th month). Starting from 
the 8th month, an inverse, statistically significant difference 
was observed, with a higher LF power for female animals. 
Starting from the 10th month, almost the same, declined LF 
values were observed in both male and female animals. The 
similar course of the power changes in time was observed 
in the case of the HF component, but from the 8th month 
on, both male and female rats reached almost the same, 
parallel values.
For both normalized components, nLF and nHF, some 
more irregular changes were observed in following months, 
which were more marked in males. Female rats demonstrated 
some gentle, more linear nLF/nHF changes in time.
The detailed illustration of the trend of changes of the basic 
and the normalized spectral HRV components are given in 
Figures 2–7 (each of the graphs represents the mean values 
for each month). Moreover, the curve, created by connecting 
points for individual months, demonstrates also hypothetical 
values for those months in which no HRV assessment was 
performed.
Table 2. Results and statistical analysis of logarithmic NA values (mean ± SD) and spectral HRV parameters (mean ± SD) in male and female rats in 
individual months of the experiment
NA
[ng/ml]
p
TP
[ln ms2]
p
VLF
[ln ms2]
p
LF
[ln ms2]
p
HF
[ln ms2]
p
nLF
[ln n.u.]
p
nHF
[ln n.u.]
p
2M
Male 2.79±0.13
0.27
3.99±0.52
0.21
3.13±0.23
0.46
2.23±1.21
0.30
2.88±0.88
0.09
4.17±0.14
0.02
3.51±0.30
0.05
Female 2.85±0.10 3.63±0.77 3.17±0.78 1.83±0.77 1.97±0.97 3.95±0.13 3.86±0.15
3M
Male 2.81±0.12
0.21
4.19±0.46
0.24
3.70±0.68
0.35
2.26±0.51
0.23
1.92±1.46
0.31
3.76±0.66
0.15
3.87±0.36
0.22
Female 2.91±0.21 3.80±0.93 3.45±1.08 1.85±0.90 1.56±0.91 4.05±0.05 3.75±0.07
4M
Male 2.32±0.67
0.40
4.27±0.08
0.10
3.60±0.65
0.41
2.47±0.18
0.05
2.64±0.78
0.02
3.78±0.44
0.17
3.95±0.27
0.19
Female 2.41±0.51 3.96±0.45 3.68±0.56 1.74±0.77 1.55±0.67 3.99±0.11 3.81±0.15
6M
Male 2.32±0.55
0.26
4.30±0.15
0.19
3.82±0.56
0.20
2.31±0.32
0.15
2.45±0.82
0.36
3.79±0.43
0.30
3.94±0.26
0.38
Female 2.16±0.03 3.09±1.31 2.64±1.35 1.22±1.78 1.45±1.75 3.61±0.57 4.01±0.41
8M
Male 2.42±0.24
0.001
3.29±0.86
0.05
2.13±1.13
0.08
0.96±0.80
0.04
1.86±1.29
0.44
3.30±0.67
0.14
4.20±0.24
0.14
Female 1.60±0.34 4.07±0.14 3.43±0.76 1.90±0.55 1.92±1.54 3.82±0.56 3.85±0.42
10M
Male 1.63±0.31
0.001
3.60±0.77
0.08
3.27±0.80
0.01
0.94±1.36
0.38
1.30±1.64
0.39
3.68±0.32
0.07
4.04±0.28
0.16
Female 0.29±0.42 3.02±0.44 2.23±0.12 1.54±1.01 1.53±0.99 3.91±0.07 3.91±0.07
12M
Male 0.48±0.74
0.33
2.88±0.87
0.15
2.76±0.96
0.13
-0.44±0.70
0.36
-0.33±0.80
0.27
3.75±0.77
0.48
3.85±0.37
0.39
Female 0.32±0.42 2.10±1.01 1.78±1.29 -0.16±1.20 -0.06±0.50 3.77±0.55 3.91±0.33
Figure 1. Trend of mean noradrenaline concentration [ng/ml] changes during the 
experiment in male and female rats
* p<0.05
Figure 2. Trend of mean total power (TP) [ms2] changes during the experiment 
in male and female rats
* p<0.05
Figure 3. Trend of mean very low frequency (VLF) power [ms2] changes during the 
experiment in male and female rats
* p<0.05
53
Journal of Pre-Clinical and Clinical Research, 2016, Vol 10, No 1
Łukasz Dobrek, Jolanta Kaszuba-Zwoińska, Agnieszka Baranowska, Beata Skowron, Piotr Thor. Resting heart rate variability and plasma noradrenaline level…
DISCUSSION
To sum up, the presented study confirmed that aging in rats 
is associated with the global HRV decrease. However, in 
resting HRV recordings obtained from anaesthetized rats, no 
preferential, aging-related parasympathetic or sympathetic 
impairment could be demonstrated.
According to the authors’ knowledge, this is the first 
experimental study focusing on the assessment of resting 
changes in the ANS activity assessed by heart rate variability 
in mature, intact, aging rats.
As already mentioned in the Introduction, body function 
deteriorates with age and that impairment involves also 
the autonomic nervous system function. Therefore, the 
autonomic modulation of circulation, metabolism and 
digestion processes, resulting from the sympathetic and 
parasympathetic dysregulation, impairs the internal 
homeostasis [17].
Clinical studies also demonstrated that aging was 
associated with depressed HRV. In the 24-hour Holter 
recordings, Reardon et  al. [18] proved that aging reduced 
the global HRV measure and concluded that the process 
may reflect a reduced responsiveness of autonomic activity 
to various stimuli with age. In another study performed by 
Akhter et al. [19], cardiac autonomic impairment with the 
advancement of age was demonstrated, and the detailed HRV 
analysis demonstrated a decreased parasympathetic function. 
Those findings were confirmed by Shankar and Veeraiah 
[20] who demonstrated a parasympathetic dysfunction in 
the elderly, using classical Ewing’s clinical autonomic tests 
(deep breathing, Valsalva maneuver, standing orthostatic 
response). Therefore, the clinical thesis of progressive, global 
ANS tension reduction with the particular withdrawal of the 
parasympathetic activity is well documented in humans. 
Besides, it should be also mentioned that taking into account 
that the reduced share of the vagus nerve in the regulation of 
the heart rate is an unfavourable prognosis associated with 
an increased risk of serious cardiovascular events in people 
of advanced age, HRV analysis can be a useful, non-invasive 
tool for assessment of the function of the cardiovascular 
system in those patients [21]
There are also studies investigating both age and gender-
dependent HRV changes in healthy subjects, e.g. Yukishita 
et al. [17] studied healthy volunteers in their 20s, 30s and 40+. 
In the analysis of 3-minute-long, resting ECG recordings 
the authors demonstrated that all HRV parameters were 
significantly negatively correlated with age in both men and 
women. Moreover, younger men (20s and 30s) demonstrated 
higher values of HRV parameters while HRV parameters 
reached higher values in 40+ women.
To sum up, clinical studies demonstrated a decline of 
the global autonomic activity with age, with marked 
parasympathetic dysfunction, more pronounced in elderly 
male subjects.
The HRV results in the presented study are partly consistent 
with those mentioned above, although it is obvious that one 
should not uncritically compare experimental and clinical 
results. However, the HRV spectrum in healthy rats resembles 
the human one. It also consists of 3 principal components: 
VLF, LF and HF, although due to the significantly higher 
heart and respiration rates, compared to those occurring in 
humans, the adopted rats’ frequency ranges for individual 
HRV spectral components are different. In ECG recordings 
Figure 7. Trend of mean normalized high frequency (nHF) power [n.u.] changes 
during the experiment in male and female rats
* p<0.05
Figure 4. Trend of mean low frequency (LF) power [ms2] changes during the 
experiment in male and female rats
*p<0.05
Figure 5. Trend of mean high frequency (HF) power [ms2] changes during the 
experiment in male and female rats
* p<0.05
Figure 6. Trend of mean normalized low frequency (nLF) power [n.u.] changes 
during the experiment in male and female rats
*p<0.05
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obtained with a telemetric system from conscious rats, the 
HF peak appeared usually between 1 – 2.5 Hz (in accordance 
with the vagally-mediated, respiratory frequency in the rat) 
while the LF was detected at 0.2– 0.8 Hz [15, 22]. VLF band 
is often set up at about to 0.2 Hz [24]. These experimental 
data demonstrate that atropine administration significantly 
reduced HF while LF power decreased after the therapy 
with propranolol in rats [22, 24]. Therefore, in the analysis 
of the HRV in rats, with an acceptable approximation, one 
can adopt a similar interpretation assumptions as those 
validated in humans.
Thus, compared to clinical data, the current study also 
demonstrated a progressive reduction of overall autonomic 
activity (TP with NA concentration decreases) throughout 
the period between month 2 – 12. Also, considering the 
segmental LF decline, and the HF decline being more 
continuous for the final months of the study, the theory 
of a progressive, functional trend of both sympathetic and 
parasympathetic decrease with age could be stated. However, 
there is a discrepancy related to the analysis of normalized 
spectral components. Starting from the 6th month, in the 
overall analysis the nHF values were higher than nLF. Also, 
HF values were higher than LF in each month of the study, 
except for the last, 12th month. Therefore, in contrast to 
clinical data, the current study has not demonstrated any 
selective parasympathetic withdrawal in older age groups 
of animals.
Limitations of the study. The performed HRV analysis in 
rats adequately reflects the overall direction of physiological 
changes observed during the aging of the human ANS (but 
without revealing preferential impaired parasympathetic 
activity with age). Hence, that model may be applied to 
studies on the ANS aging assessing the overall changes of 
ANS activity. Moreover, it should be remembered, that those 
changes merely reflect the resting ANS activity and do not 
allow assessment of the dynamic autonomic response to any 
stimulation. In addition, even though rats are often used for the 
ANS studies, the key issues limiting widespread HRV studies 
in rats involve inadequate reproducibility of data related to 
difficulties in maintaining stable experimental conditions 
and a high behavioural sensitivity to environmental changes 
[23].
Moreover, this research was performed in anaesthetized 
rats and many available, published experimental studies, 
had been performed on conscious but restrained animals 
(conscious unrestrained animal studies are scare). Under 
anesthesia, the heart rate fluctuates, being a basis for its 
variability, are also influenced; therefore, HRV should be 
recorded in a precisely induced, shallow anesthesia [24, 
25]. On the other hand, however, ECG in anesthetized 
rats is a compromise between the technical possibility of 
obtaining results of the HRV in general and the inevitable 
influence of the anesthetic agent on the obtained results. 
Similar objections are related to the ECG registration in 
conscious but restrained animals – the stress associated 
with immobilization also undoubtedly affect obtained HRV 
results.
Moreover, the influence of pentobarbital on the heart rate 
that is the background for subsequent heart rate variability 
is still open and a disputed issue. Literature data suggest that 
pentobarbital anesthesia in rats impairs baroreceptor activity 
and, consequently, results in a reduction of tachycardia, and 
a fall in blood pressure [26, 27]. However, according to some 
authors, the effect of pentobarbital on the resting heart rate 
(HR) in rats is slight, and it manifests by a daily modulation 
of heart rate (day-night differences) rather than by evoking 
of marked bradycardia after administration of single dose 
of that agent [28]. Therefore, according to Svorc et al. [28], 
the ECG registration (with subsequent HRV analysis) within 
the daylight period in rats anesthetized with pentobarbital, 
is acceptable if HR still remains within the reference for this 
species (250–500 / min) [14] because pentobarbital-mediated 
bradycardia resulted from vagal stimulation, is compensated 
by a parallel increase of the sympathetic activity. In the 
presented experiment, the heart rate of all studied rats in 
all the studied months remained within the normal range.
CONCLUSIONS
The main finding of this study is the demonstration that, in 
general, all non-normalized HRV parameters and the HRV 
total power decline with age, in both overall assessment and in 
gender-dependent estimation. Additionally, the reduced HRV 
was accompanied by a progressive decline in serum levels of 
noradrenaline. In general, male rats achieved comparable or 
higher HRV parameter values compared to female animals. 
On the other hand, in the case of females, a lower imbalances 
between sympathetic (nLF) and parasympathetic (nHF) 
tension in the course of study months was demonstrated, 
compared to males in which nLF-nHF changes were more 
irregular. A generalized reduction of ANS activity was not 
associated with selective functional ANS rebuilding, with 
selective impairment of one ANS branch.
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